Trial Profile
Phase II study of antineoplaston A10/antineoplaston AS2-1 in paediatric patients with recurrent diffuse intrinsic pontine glioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2014
Price :
$35
*
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Diffuse intrinsic pontine glioma; Glioma
- Focus Therapeutic Use
- 11 Mar 2014 New trial record